BGM Group Ltd. (BGM) stock
BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
$8.01+0.13 (+1.71%)
Close on Nov 16, 2026Market cap $3.21BP/E –Yield –
BGM EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -$0.18. The highest annual figure on record is $0.90 in fiscal 2019.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$0.18 | – |
| FY2024 | Sep 30, 2024 | -$0.20 | – |
| FY2023 | Sep 30, 2023 | -$1.08 | -820.0% |
| FY2022 | Sep 30, 2022 | $0.15 | -66.7% |
| FY2021 | Sep 30, 2021 | $0.45 | -47.1% |
| FY2020 | Sep 30, 2020 | $0.85 | -5.6% |
| FY2019 | Sep 30, 2019 | $0.90 | +5.9% |
| FY2018 | Sep 30, 2018 | $0.85 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?